FDA Inspection
Reliance Life Sciences Private LimitedReliance Life Sciences Private Limited – FDA Inspection, Aug 14, 2015
Record Details
This FDA Inspection record concerns Reliance Life Sciences Private Limited, with an inspection on August 14, 2015, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 14, 2015
- Product Type
- Drugs
View Company Profile
ID · 31fccf0e-5d28-486d-93c4-e941ab976fbf
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 940150
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Reliance Life Sciences Private Limited
9| Date | Classification | Office | Project area |
|---|---|---|---|
| February 27, 2026 | Not classified | Office of Inspections and Investigations | |
| April 15, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| November 22, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 22, 2019 | VAI | Office of Inspections and Investigations | Generic Drug Evaluation |
| October 16, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Reliance Life Sciences Private Limited
- FDA Inspection 1311632 - 2026-02-27
- FDA Inspection 1170339 - 2022-04-15
- FDA Inspection 1113122 - 2019-11-22
- FDA Inspection 1081821 - 2019-02-22
- FDA Inspection 1070144 - 2018-10-16
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.